Open AccessB-mode and contrast-enhancement characteristics of small nonincidental neuroendocrine pancreatic tumors
Author(s) -
Barbara Braden,
Christian Jenssen,
Mirko D’Onofrio,
Michael Hocke,
Uwe Will,
Kathleen Möller,
A. Ignee,
Dong Ye,
XinWu Cui,
Adrian Săftoiu,
Christoph F. Dietrich
Publication year - 2017
Publication title -
endoscopic ultrasound
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.883
H-Index - 24
eISSN - 2303-9027
pISSN - 2226-7190
DOI - 10.4103/2303-9027.200213
Subject(s) - gastrinoma , men1 , neuroendocrine tumors , medicine , multiple endocrine neoplasia , pancreas , insulinoma , chromogranin a , contrast enhanced ultrasound , radiology , contrast (vision) , glucagonoma , endoscopic ultrasound , endocrine system , pathology , ultrasound , hormone , immunohistochemistry , gastrin , chemistry , biochemistry , artificial intelligence , secretion , computer science , gene
Imaging of the pancreas for detection of neuroendocrine tumors is indicated as surveillance in multiple endocrine neoplasia type 1 (MEN1) or if typical clinical symptoms combined with hormone production raise the suspicion of a neuroendocrine tumor. Endoscopic ultrasound (EUS) is considered the best imaging modality to detect small pancreatic tumors. However, little is known about how small pancreatic neuroendocrine tumors (pNETs) present on EUS.